June 30th was the end date of an ambitious and successful financial program held by OSEO, the French Innovation Agency, established to support the release of of the last version of the AdClin Normalizer™.
During a year and a half, OSEO has been supporting our development, granting us up to 30% of the total costs, including research, programming and marketing activities. With the upcoming release of this last version next fall, the contract established between AdClin and OSEO has come to an end. This is the third successful collaboration of AdClin and OSEO and the second related to software development.
The AdClin Normalizer™, used to quickly and securely transform clinical data to CDISC standards (SDTM/ADaM), is our highly productive and secured inhouse software environment.